Skip to main content

MoneyWorks4Me

Lupin informs about press release

09 Dec 2022 Evaluate
Lupin has informed that it enclosed a Press Release as regards, launch of authorized generic version of PENNSAID (Diclofenac Sodium Topical Solution), 2% w/w of Horizon Pharma Therapeutics. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.75
Dr. Reddys Labs. 1312.60
Cipla 1344.65
Lupin 1950.50
Zydus Lifesciences 1169.00
View more..